Doselane

Guides

Where to inject Ozempic, Wegovy, Mounjaro and Zepbound, and how to rotate sites

A semaglutide injection pen and its blue cap on a white surface

Photo: Haberdoedas / Unsplash

All four weekly GLP-1 labels name the same three areas: the abdomen, the thigh and the upper arm. They also agree on one habit: use a different spot with every dose. The labels don't name a "best" area.

The three areas

Injection areas: abdomen at least 2 inches from the belly button, thigh, and the back of the upper armWhere the labels say to injectSchematic, not to scaleFrontBackAbdomen2 in (5 cm) fromthe belly buttonThighBack ofupper armUpper arm: someoneelse gives the injection
The three areas named in the labels. The 2-inch distance is from the Ozempic and Wegovy instructions for use; the Mounjaro and Zepbound labels say another person injects in the back of the upper arm.

The NHS puts it as the fatty areas of your thigh, tummy or upper arm (for tirzepatide: the back of your upper arm).

Is one area better?

None of the four labels names a preferred area. The Wegovy label says that the time of day and the injection site "can be changed without the need for a dosage modification." If one area is easier or more comfortable for you, ask your prescriber, pharmacist or nurse; the Ozempic instructions note that your healthcare provider can help you choose the site that is best for you.

Rotating sites

This is the one thing every source repeats:

The labels don't prescribe a pattern. One simple way to keep track, as an example only: move around a fixed order, such as left abdomen, right abdomen, left thigh, right thigh, and write down where each dose went. The record matters more than the order: it answers "where did I inject last week?" without guessing.

Doselane's Today screen, shown with example data: the next shot, with the suggested site from your own rotation.
Doselane's Today screen, shown with example data: the next shot, with the suggested site from your own rotation.

If you also inject insulin

The Ozempic and Mounjaro labels say: give them as separate injections and never mix them. You can inject both in the same body region, but not right next to each other. The NHS says to use a different place for each.

Injection site reactions

Redness, itching, bruising or discomfort where you injected are listed in every label. How often they were reported differs:

Injection site reactions: Ozempic 0.2%; Wegovy 1.4% vs 1% placebo; Mounjaro 3.2% vs 0.4%; Zepbound 8% vs 2%Injection site reactions in the trials% of people, as reported in each US label0%2%4%6%8%10%Ozempic0.5 and 1 mg pooled0.2%placebo not givenWegovy2.4 mg1.4%1%Mounjaroall doses pooled3.2%0.4%Zepbound10 mg and 15 mg8%2%MedicinePlacebo
Different trials, people and definitions, so this is not a head-to-head comparison. Zepbound 5 mg: 6%.

The NHS lists "itchy or red skin where you inject" among the common side effects of tirzepatide. Get medical help right away if you have signs of a serious allergic reaction, such as swelling of your face, lips, tongue or throat, or problems breathing or swallowing; the Ozempic Medication Guide also lists severe rash or itching, fainting or feeling dizzy, and a very rapid heartbeat.

Keeping the pen between doses

Storage is different for each pen, and it is printed in each label (section 16) and in the leaflet in your pack. Before first use, all of the pens below are kept in the fridge at 36°F to 46°F (2°C to 8°C). Out of the fridge, the US labels say:

PenOut of the fridge
Ozempic penafter first use: 56 days at 59°F to 86°F (15°C to 30°C), or in the fridge
Wegovy FlexTouchafter first use: 56 days at 59°F to 86°F (15°C to 30°C), or in the fridge
Wegovy single-dose penif needed, before the cap is removed: up to 28 days at 46°F to 86°F (8°C to 30°C)
Mounjaro / Zepbound single-dose penif needed: up to 21 days in total, not above 86°F (30°C)
Mounjaro / Zepbound KwikPenunopened: thrown away after 30 days at room temperature (up to 86°F / 30°C); opened: thrown away after 30 days or 4 weekly doses

All four labels say: never freeze the pen, don't use it if it has been frozen, and protect it from heat and light. Check the leaflet in your own pack, because pens differ by country and presentation.

This page is general information from the sources below, not medical advice. Follow the instructions for use that come with your pen, and ask your prescriber, pharmacist or nurse to show you how to inject.

Sources
  1. Ozempic (semaglutide) injection: US Prescribing Information, Medication Guide and Instructions for Use, Novo Nordisk, revised 05/2026 (sections 2.1, 6.1 and 16), checked 20 November 2026.
  2. Wegovy (semaglutide) injection and tablets: US Prescribing Information and Instructions for Use, Novo Nordisk, revised 06/2026 (sections 2.1, 6.1 and 16), checked 20 November 2026.
  3. Mounjaro (tirzepatide) injection: US Prescribing Information, Eli Lilly, revised 11/2026 (sections 2.2, 6.1 and 16.2), checked 20 November 2026.
  4. Zepbound (tirzepatide) injection: US Prescribing Information, Eli Lilly, revised 11/2026 (sections 2.4, 6.1 and 16.2), checked 20 November 2026.
  5. NHS: Semaglutide and NHS: Tirzepatide, checked 20 November 2026.